Catheter with variable stiffness

Information

  • Patent Grant
  • 8821478
  • Patent Number
    8,821,478
  • Date Filed
    Friday, March 2, 2012
    12 years ago
  • Date Issued
    Tuesday, September 2, 2014
    10 years ago
Abstract
Medical devices and methods for making and using medical devices are disclosed. An example medical device may include an elongate inner member having a guidewire lumen extending therethrough. An outer member may be disposed about the inner member. An inflation lumen may be formed between the inner member and the outer member. The medical device may be configured to have a first stiffness when the inflation lumen is free of inflation media and a second stiffness different from the first stiffness when inflation media is disposed within the inflation lumen. In addition, the inner member may include a collapsible region that is configured to deflect radially inward when inflation media is disposed within the inflation lumen.
Description
TECHNICAL FIELD

The present invention pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present invention pertains to catheters that can vary in stiffness


BACKGROUND

A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.


BRIEF SUMMARY

The invention provides design, material, manufacturing method, and use alternatives for medical devices. An example medical device may include an elongate inner member having a guidewire lumen extending therethrough. An outer member may be disposed about the inner member. An inflation lumen may be formed between the inner member and the outer member. The medical device may be configured to have a first stiffness when the inflation lumen is free of inflation media and a second stiffness different from the first stiffness when inflation media is disposed within the inflation lumen. In addition, the inner member may include a collapsible region that is configured to deflect radially inward when inflation media is disposed within the inflation lumen.


An example method for navigating a medical device through the vasculature may include providing a catheter. The catheter may include an elongate inner member having a guidewire lumen extending therethrough, an outer member disposed about the inner member, and an inflation lumen, which may be defined between the inner member and the outer member. The method may also include advancing a guidewire through the vasculature to a position adjacent to an area of interest, advancing the catheter over the guidewire, and infusing inflation media into the inflation lumen. Infusing inflation media into the inflation lumen may increase the stiffness of the catheter and it may deflect a portion of the inner member radially inward such that the inner member engages the guidewire.


An example variable stiffness catheter may include a catheter shaft. The catheter shaft may include an inner shaft and an outer shaft. A lumen may be formed between the inner shaft and the outer shaft. Infusion of a media into the lumen may increase the stiffness of the catheter shaft. Additionally, the inner shaft may have a collapsible region that is configured to deflect radially inward when media is infused into the lumen.


The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:



FIG. 1 is a side view of an example catheter disposed over a guidewire;



FIG. 2 is a cross-sectional side view of a portion of the example catheter and guidewire shown in FIG. 1;



FIG. 3 is a cross-sectional side view of the example catheter and guidewire shown in FIGS. 1-2 with inflation media disposed therein;



FIG. 4 is an alternative cross-sectional side view of the example catheter and guidewire shown in FIGS. 1-3 with inflation media disposed therein;



FIG. 5 is a cross-sectional side view of another example catheter and guidewire with inflation media disposed therein;



FIG. 6 is a cross-sectional side view of an example catheter disposed in a body lumen;



FIG. 7 is a cross-sectional side view of the example catheter shown in FIG. 6 with inflation media disposed therein;



FIG. 8 is a cross-sectional side view of the example catheter shown in FIGS. 6-7 extending across a chronic total occlusion; and



FIG. 9 is a cross-sectional side view of a portion of another example catheter.


While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.





DETAILED DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.


The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).


As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.



FIG. 1 is a side view of an example catheter 10. Catheter 10 may include a catheter shaft 12. A hub 14 may be coupled to the proximal end of catheter shaft 12. In general, catheter 10 may be a number of different interventions and may be configured to be advanced over or otherwise track over a guidewire 16. For example, catheter 10 may be a crossing catheter that is configured to cross tight lesions such as chronic total occlusions. This may include calcified lesions or occlusions. In addition or in the alternative, catheter 10 may be a guide catheter, a catheter for diagnosing and/or treating a medial condition, a delivery catheter (e.g., for stents, grafts, leads, or the like), or any other suitable medical device. In some embodiments, catheter 10 may include an inflatable balloon (not shown). In other embodiments, for example as shown, catheter 10 may be free of an expandable balloon. Indeed, catheter 10 may be thought of or take the form of a balloon catheter “without the balloon”.



FIG. 2 is a partial cross-sectional side view of a portion of catheter 10. Here it can be seen that catheter 10 (e.g., catheter shaft 12) includes an inner shaft or member 18. Inner shaft 18 may define a lumen 20 at least partially the length therethrough. In at least some embodiments, lumen 20 is a guidewire lumen. However, lumen 20 may also be an infusion and/or aspiration lumen. Other uses are also contemplated. In some embodiments, inner lumen 18 may include one or more additional lumens (not shown). Catheter shaft 12 may also include an outer shaft or member 22. Between inner shaft 18 and outer shaft 22, another lumen 24 may be defined. Lumen 24 may be thought of as an inflation lumen or otherwise may include a lumen into which media such as inflation media can be infused.


In the illustrated embodiment, inner shaft 18 is shown as having a length that is substantially the same as outer shaft 22. In other words, inner shaft 18 may extend along substantially the entire length of catheter shaft 12. Accordingly, guidewire lumen 20 may also extend along substantially the entire length of catheter 12 such that catheter 10 is an “over-the-wire” catheter. This, however, is not intended to be limiting as other catheters are contemplated where catheter 10 is a “single-operator-exchange” or “rapid-exchange” catheter, as these terms would be understood by one skilled in the art. In these embodiments, inner shaft 18 may extend along only a distal portion of outer shaft 22 and a port or opening (not shown) may be formed in the wall of outer shaft 22 that provides access to guidewire lumen 20.


Inner shaft 18 and outer shaft 22 may have a number of different configurations and/or material compositions. For example, inner shaft 18, outer shaft 22, or both may include one or more layers of material. In one example, inner shaft 18 may include three layers of material including an inner layer, and outer layer, and a tie layer disposed therebetween. In addition, inner shaft 18, outer shaft 22, or both may include a reinforcing structure such as a braid, mesh, coil, or other structure (not shown). This may provide catheter shaft 12 with improved strength.


One or more marker members or bands 23 may be disposed on inner shaft 18. Marker bands 23 may allow a clinician to more easily visualize catheter 10 under fluoroscopy or other visualization techniques (e.g., MRI, etc.). Because marker bands 23 are disposed on inner shaft 18 and because outer shaft 22 is also disposed about inner shaft 18, marker bands 23 may be covered or “encapsulated” within catheter shaft 12. Accordingly, marker bands 23 may be not exposed along the exterior of catheter shaft 12 where they might otherwise be susceptible to snagging or catching along the vasculature.


When using catheters (e.g., catheter 10) to gain access to lesions within the vasculature, it may be useful for the catheters to be highly flexible. This is because, for example, the vasculature may include a number of relatively sharp bends or take-offs. When navigating and/or treating the anatomy, it is possible that the catheter may encounter a lesion such as what is known as a chronic total occlusion. Such occlusion, which may be calcified or otherwise hardened, may be difficult to navigate through and/or treat, particularly with a highly flexible catheter.


Catheter 10 may be designed so as to have desirable flexibility characteristics so that it may be efficiently navigated through the anatomy (e.g., its flexibility may be comparable to that of catheters that are typically used to gain access to a variety of points within the vasculature). In addition, in order to more efficiently cross lesions such as a chronic total occlusions, catheter 10 may also have a variable flexibility or stiffness. Because of this, it may be possible for the clinician to alter the stiffness of catheter 10 (e.g., may provide “on demand” variability in stiffness) during a vascular intervention so that the flexibility and/or stiffness characteristics of catheter 10 can be tailored to the needs of the intervention. For example, catheter 10 may be configured to be relatively flexible so that it can efficiently navigate sharp bends or turns in the anatomy. In addition, catheter 10 may also be configured so that a clinician can increase the stiffness thereof, which may allow catheter 10 to be used to and/or aid in more efficiently crossing an occlusion such as a chronic total occlusion.


In at least some embodiments, catheter 10 may be configured to have a varying stiffness through the infusion of media 26 for example inflation media, into lumen 24 as shown in FIG. 3 (note that lumen 24 is not labeled in FIGS. 3-5 due to the presence of media 26 but can be seen in FIG. 2). Media 24 may include any suitable media including a liquid or fluid (e.g., inflation media, saline, water, other fluids, etc.), a gas, colloidal materials, combinations thereof, and the like. In at least some embodiments, media 26 may be infused into lumen 24 using an inflation device such as those used commonly in the art. Other devices may also be used to infuse media 26 into lumen. The presence of the media 26 within lumen 24 may provide additional stiffness that may allow catheter 10 to have a greater ability to push through or otherwise past, for example, an occlusion. For example, when lumen 24 is substantially free of inflation media 26, catheter 10 may be sufficiently flexible so that it can navigate the anatomy. Infusing media 26 into lumen 24 may increase the stiffness of catheter 10, for example to hydraulic pressure exerted onto catheter shaft 12 by media 26. Indeed, the overall stiffness may be proportional to the amount of media 26 disposed in lumen 24. For example, a relatively small amount of media 26 (e.g., enough to fill lumen 24 but only exert a relatively small amount pressure onto inner shaft 18, outer shaft 22, or both) may increase the stiffness of catheter 10. This may include infusing sufficient media 26 into lumen 24 so that the total pressure within lumen 24 is in the range of about 0-4 pounds per square inch (PSI), or about 0-2 PSI, or about 2 PSI. Further infusion of media 26 (e.g., enough to pressurize lumen 24 such that increased force is applied to inner shaft 18, outer shaft 22, or both) may further stiffen catheter 10. This may include infusing sufficient media 26 into lumen 24 so that the total pressure within lumen 24 is in the range of about 2-16 PSI or more, or about 2-10 PSI or more, or about 2-8 PSI or more, or about 2-6 PSI or more. It can be appreciated that a large variety of stiffnesses can be achieved for catheter 10, depending on the quantity or “pressurization” of media 26 with lumen 24. While not wishing to be bound by theory, it is believed that once the pressure within lumen 24 reaches about 6 PSI, the stiffness begins to level off so that further infusion of media 26 may only alter the stiffness in relatively small increments.


It can be appreciated that in order to contain media 26, inner shaft 18 and outer shaft 22 may be attached, for example at their distal ends, and form a closed tip. The exact configuration of the tip can vary. For example, some embodiments may include a relatively gentle taper so as to provide catheter 10 with an atraumatic tip. Some of this and other embodiments may include an elongated tip or low profile tip, which may allow catheter 10 to probe deeper within the anatomy and within relatively narrow locations including the neurological vasculature.


In addition to having a variable stiffness, inner member 18 may also be configured to deflect radially inward or otherwise collapse as shown in FIG. 4. In doing so, inner member 18 may exert force onto guidewire 16. This may be desirable for a number of reasons. For example, the deflection or collapse of inner shaft 18 may allow catheter 10 to grab onto or otherwise hold guidewire 16. This may allow a clinician to effectively move guidewire 16 in a predictable manner or otherwise provide greater control to the clinician of guidewire 16. In addition, by collapsing onto guidewire 16, catheter 10 may provide additional stiffness and/or pushability to guidewire 16, which may allow guidewire 16 to pass through some lesions and/or occlusions.


While FIG. 4 illustrates that in some instances, inner member 18 may be collapsible along substantially its entire length, other embodiments are contemplated where less than the full length of inner member 18 may collapse. For example, FIG. 5 illustrates catheter 10 where inner member 18 has a discrete section 28 that is configured to deflect radially inward or otherwise collapse when inflation media 26 is infused within lumen 24. In some embodiments, section 28 is defined during the manufacture of inner shaft 18 due to its shape, thickness, material composition, or other physical features. In other embodiments, inner member 18 may be simply collapsed at one or more discrete locations due to the positioning and/or location of catheter shaft 12 within the anatomy. It can be appreciated that some embodiments of inner shaft 18 include a plurality of discrete sections 28 (which may be spaced along the length of inner shaft 18) including two, three, four, five, six, seven, eight, nine, ten, or more sections 28. These are just examples.



FIGS. 6-8 illustrate one example of some of the uses of catheter 10. For example, FIG. 6 illustrates catheter 10 advanced through a blood vessel 30 over guidewire 16 to a position adjacent to an occlusion 32. Upon reaching the occlusion, a number of steps may be taken to improve the possibility that catheter 10 can be advanced through occlusion 32. For example, a clinician may attempt to simply push or advance guidewire 16 and/or catheter 10 through occlusion 32. If not successful, guidewire 16 may be retracted and another guidewire, for example a stiffer guidewire, may be advanced through catheter 10 and another attempt to cross occlusion 32 may be made. In either instance, further attempts to cross occlusion 32 may be made with catheter 10 disposed about guidewire 16 or a different guidewire (e.g. while “supporting” guidewire 16). This may include supporting guidewire 16 by disposing catheter 10 (either pressurized or non-pressurized) adjacent to occlusion 32 while attempting to navigate guidewire 16 through occlusion 32. In addition, contrast media (not shown) can be passed through catheter 10 (e.g., through guidewire lumen 20) in order to better visualize occlusion 32. This may occur at any suitable time during the intervention.


Ultimately, it may be decided that additional pushability and/or stiffness may be necessary in order to cross occlusion 32. Accordingly, inflation media 26 may be infused into lumen 24 as shown in FIG. 7. This may provide additional stiffness to catheter 10 as described herein so that catheter 10 may be advanced through occlusion 32 as shown in FIG. 8. If initially pressurization is not sufficient to allow catheter 10 to cross occlusion 32, additional pressurization may be used (e.g., additional media 26 may be infused into catheter 10), which may further stiffen catheter 10, and further attempts may be made to cross occlusion 32. Some of these attempts may include pressurizing catheter 10 sufficiently to add stiffness to catheter 10 (which may or may not include collapsing inner shaft 18 onto guidewire 16), positioning catheter 10 adjacent to occlusion 32, and attempting to navigate guidewire 16 through occlusion 32 while catheter 10 supports guidewire 16. In addition, as described herein infusion of media 26 may also cause inner shaft 18 to collapse onto guidewire 16, which may provide additional support to guidewire 16 and/or allow the clinician to easily modify the position of guidewire 16 within the vessel 30. Once catheter 10 and guidewire 16 successfully cross occlusion 32, catheter 10 may be retracted and another treatment and/or diagnostic catheter or medical device may be passed over guidewire 16 and across occlusion 32.



FIG. 9 illustrates another example catheter 110 that may be similar in form and function to catheter 10. Catheter 110 includes catheter shaft 112 having inner shaft 118 and outer shaft 122. Marker bands 123 may be attached to inner shaft 118. Just like with catheter 10, inflation media 126 may be infused into the lumen (similar to lumen 24) formed between inner shaft 118 and outer shaft 122. In doing so, section 128 of inner shaft 118 may deflect radially inward and engage guidewire 16. In this example, section 128 is shown as a discrete section 128 of inner shaft 118. This, however, is not intended to be limiting as inner shaft 118 may also be configured to be collapsible along substantially its entire length.


Outer shaft 122 may include a deflectable portion 134. In this example, deflectable portion 134 is configured to deflect radially outward. In at least some embodiments, portion 134 may resemble a balloon or inflatable structure that deflects radially outward when inflation media 126 is infused into catheter 110. Deflection portion 134 may extend along only a discrete portion of outer shaft 122 (e.g., along a distal region), along multiple discrete portions of outer shaft 122, or along substantially the entire length of outer shaft 122. Deflectable portion 134 may be desirable for a number of reasons. For example, portion 134 may be used to expand or otherwise break up an occlusion (e.g., like occlusion 32) so that catheter 110 can be advanced through the occlusion. For example, catheter 110 may be advanced partially through or into an occlusion and deflectable portion 134 may be enlarged (e.g., deflected radially outward) to help break up the occlusion.


The materials that can be used for the various components of catheter 10 (and/or other catheters disclosed herein) and the various catheter shafts disclosed herein may include those commonly associated with medical devices. For simplicity purposes, the following discussion makes reference to catheter shaft 12 and other components of catheter 10. However, this is not intended to limit the devices and methods described herein, as the discussion may be applied to other similar tubular members and/or components of tubular members or devices disclosed herein.


Catheter shaft 12 and/or other components of catheter 10 may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.


As alluded to herein, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve like super elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear that the super elastic plateau and/or flag region that may be seen with super elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.


In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also can be distinguished based on its composition), which may accept only about 0.2 to 0.44 percent strain before plastically deforming.


In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensite/austenite phase changes that are detectable by differential scanning calorimetry (DSC) and dynamic metal thermal analysis (DMTA) analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60 degrees Celsius (°C.) to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. In other words, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties.


In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.


In at least some embodiments, portions or all of catheter shaft 12 may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of catheter 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of catheter 10 to achieve the same result.


In some embodiments, a degree of Magnetic Resonance Imaging (MRI) compatibility is imparted into catheter 10. For example, catheter shaft 12, or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (i.e., gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. Catheter shaft 12, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.


A sheath or covering (not shown) may be disposed over portions or all of catheter shaft 12 that may define a generally smooth outer surface for catheter 10. In other embodiments, however, such a sheath or covering may be absent from a portion of all of catheter 10, such that catheter shaft 12 may form the outer surface. The sheath may be made from a polymer or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.


In some embodiments, the exterior surface of the catheter 10 (including, for example, the exterior surface of catheter shaft 12) may be sandblasted, beadblasted, sodium bicarbonate-blasted, electropolished, etc. In these as well as in some other embodiments, a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of the sheath, or in embodiments without a sheath over portion of catheter shaft 12, or other portions of catheter 10. Alternatively, the sheath may comprise a lubricious, hydrophilic, protective, or other type of coating. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which improves guidewire handling and device exchanges. Lubricious coatings improve steerability and improve lesion crossing capability. Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.


The coating and/or sheath may be formed, for example, by coating, extrusion, co-extrusion, interrupted layer co-extrusion (ILC), or fusing several segments end-to-end. The layer may have a uniform stiffness or a gradual reduction in stiffness from the proximal end to the distal end thereof. The gradual reduction in stiffness may be continuous as by ILC or may be stepped as by fusing together separate extruded tubular segments. The outer layer may be impregnated with a radiopaque filler material to facilitate radiographic visualization. Those skilled in the art will recognize that these materials can vary widely without deviating from the scope of the present invention.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A medical device, comprising: an elongate inner member having a guidewire lumen extending therethrough;an outer member disposed about the inner member;wherein an inflation lumen is formed between the inner member and the outer member;wherein the medical device is configured to have a first stiffness when the inflation lumen is free of inflation media and a second stiffness different from the first stiffness when inflation media is disposed within the inflation lumen; andwherein the inner member includes a collapsible region that is configured to deflect radially inward when inflation media is disposed within the inflation lumen; andwherein the medical device is free of an expandable balloon.
  • 2. The medical device of claim 1, wherein the inner member has a length and wherein the collapsible region extends along the entire length of the inner member.
  • 3. The medical device of claim 1, wherein the inner member has a length and wherein the collapsible region extends along only a portion of the length of the inner member.
  • 4. The medical device of claim 1, wherein the inner member further comprises one or more additional collapsible regions.
  • 5. The medical device of claim 1, further comprising one or more marker members disposed along the inner member.
  • 6. The medical device of claim 1, wherein the inner member has a distal end, wherein the outer member has a distal end, and wherein a sealed tip is formed between the distal end of the inner member and the distal end of the outer member.
  • 7. The medical device of claim 1, wherein the inner member includes a plurality of layers.
  • 8. A method for navigating a medical device through the vasculature, the method comprising: providing a catheter, the catheter comprising: an elongate inner member having a guidewire lumen extending therethrough,an outer member disposed about the inner member, andwherein an inflation lumen is defined between the inner member and the outer member and wherein the catheter is free of an expandable balloon;advancing a guidewire through the vasculature to a position adjacent to an area of interest;advancing the catheter over the guidewire;infusing inflation media into the inflation lumen;wherein infusing inflation media into the inflation lumen increases the stiffness of the catheter; andwherein infusing inflation media into the inflation lumen collapses a portion of the inner member radially inward along an entire length of the inner member such that the inner member engages the guidewire.
  • 9. The method of claim 8, wherein the area of interest includes a chronic total occlusion and wherein advancing the catheter over the guidewire includes advancing the catheter to the chronic total occlusion.
  • 10. The method of claim 8, wherein the catheter is free of an expandable balloon.
  • 11. The method of claim 8, further comprising infusing contrast media through the guidewire lumen.
  • 12. The method of claim 8, further comprising removing the guidewire from the guidewire lumen and advancing a second guidewire through the guidewire lumen.
  • 13. A variable stiffness catheter, comprising: a catheter shaft including an inner shaft and an outer shaft;wherein a lumen is formed between the inner shaft and the outer shaft;wherein infusion of a media into the lumen increases the stiffness of the catheter shaft;wherein the inner shaft has a collapsible region extending an entire length of the inner shaft that is configured to deflect radially inward when media is infused into the lumen, andwherein the catheter is free of an expandable balloon.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application Ser. No. 61/449,271, filed Mar. 4, 2011, the entire disclosure of which is incorporated herein by reference.

US Referenced Citations (234)
Number Name Date Kind
3472230 Fogarty Oct 1969 A
3592186 Oster Jul 1971 A
3683904 Forster Aug 1972 A
3889657 Baumgarten Jun 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3996938 Clark, III Dec 1976 A
4046150 Schwartz et al. Sep 1977 A
4425908 Simon Jan 1984 A
4447227 Kotsanis May 1984 A
4580568 Gianturco Apr 1986 A
4590938 Segura et al. May 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4631052 Kensey Dec 1986 A
4643184 Mobin-Uddin Feb 1987 A
4650466 Luther Mar 1987 A
4662885 DiPisa, Jr. May 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4706671 Weinrib Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4728319 Masch Mar 1988 A
4733665 Palmaz Mar 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4790813 Kensey Dec 1988 A
4794928 Kletschka Jan 1989 A
4794931 Yock Jan 1989 A
4800882 Gianturco Jan 1989 A
4807626 McGirr Feb 1989 A
4842579 Shiber Jun 1989 A
4857045 Rydell Aug 1989 A
4857046 Stevens et al. Aug 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4873978 Ginsburg Oct 1989 A
4898575 Fischell et al. Feb 1990 A
4907336 Gianturco Mar 1990 A
4921478 Solano et al. May 1990 A
4921484 Hillstead May 1990 A
4926858 Gifford, III et al. May 1990 A
4932959 Horzewski et al. Jun 1990 A
4950277 Farr Aug 1990 A
4955895 Sugiyama et al. Sep 1990 A
4957482 Shiber Sep 1990 A
4969891 Gewertz Nov 1990 A
4979951 Simpson Dec 1990 A
4986807 Farr Jan 1991 A
4998539 Delsanti Mar 1991 A
5002560 Machold et al. Mar 1991 A
RE33569 Gifford, III et al. Apr 1991 E
5007896 Shiber Apr 1991 A
5007917 Evans Apr 1991 A
5011488 Ginsburg Apr 1991 A
5019088 Farr May 1991 A
5041126 Gianturco Aug 1991 A
5053008 Bajaj Oct 1991 A
5053044 Mueller et al. Oct 1991 A
5071407 Termin et al. Dec 1991 A
5071425 Gifford, III et al. Dec 1991 A
5085662 Willard Feb 1992 A
5087265 Summers Feb 1992 A
5100423 Fearnot Mar 1992 A
5100424 Jang et al. Mar 1992 A
5100425 Fischell et al. Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5104399 Lazarus Apr 1992 A
5106376 Mononen et al. Apr 1992 A
5108419 Reger et al. Apr 1992 A
5116305 Milder et al. May 1992 A
5133733 Rasmussen et al. Jul 1992 A
5135531 Shiber Aug 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5152777 Goldberg et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5171233 Amplatz et al. Dec 1992 A
5190546 Jervis Mar 1993 A
5195955 Don Michael Mar 1993 A
5217434 Arney Jun 1993 A
5224953 Morgentaler Jul 1993 A
5231989 Middleman et al. Aug 1993 A
5238004 Sahatjian et al. Aug 1993 A
5306286 Stack et al. Apr 1994 A
5314444 Gianturco May 1994 A
5314472 Fontaine May 1994 A
5318576 Plassche, Jr. et al. Jun 1994 A
5324259 Taylor et al. Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5330484 Gunther et al. Jul 1994 A
5330500 Song Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5354310 Garnic et al. Oct 1994 A
5356423 Tihon et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5366473 Winston et al. Nov 1994 A
5370657 Irie Dec 1994 A
5370683 Fontaine Dec 1994 A
5376100 Lefebvre Dec 1994 A
5383887 Nadal Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5383926 Lock et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5395349 Quiachon et al. Mar 1995 A
5397345 Lazerus Mar 1995 A
5405377 Cragg Apr 1995 A
5409454 Fischell et al. Apr 1995 A
5415630 Gory et al. May 1995 A
5419774 Willard et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5423742 Theron Jun 1995 A
5423885 Williams Jun 1995 A
5425765 Tiefenbrun et al. Jun 1995 A
5443498 Fontaine Aug 1995 A
5449372 Schmaltz et al. Sep 1995 A
5456667 Ham et al. Oct 1995 A
5462529 Simpson et al. Oct 1995 A
5476104 Sheahon Dec 1995 A
5484418 Quiachon et al. Jan 1996 A
5499973 Saab Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5512044 Duer Apr 1996 A
5527354 Fontaine et al. Jun 1996 A
5531689 Burns et al. Jul 1996 A
5536242 Willard et al. Jul 1996 A
5540707 Ressemann et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5562724 Vorwerk et al. Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5569275 Kotula et al. Oct 1996 A
5634897 Dance et al. Jun 1997 A
5658296 Bates et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5695519 Summers et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5720764 Naderlinger Feb 1998 A
5728066 Daneshvar Mar 1998 A
5730734 Adams et al. Mar 1998 A
5746758 Nordgren et al. May 1998 A
5749848 Jang et al. May 1998 A
5749849 Engelson May 1998 A
5769816 Barbut et al. Jun 1998 A
5772609 Nguyen et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5792300 Inderbitzen et al. Aug 1998 A
5795322 Boudewijn Aug 1998 A
5797952 Klein Aug 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5833604 Houser et al. Nov 1998 A
5833644 Zadno-Azizi et al. Nov 1998 A
5833650 Imran Nov 1998 A
5846260 Maahs Dec 1998 A
5848964 Samuels Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5879324 von Hoffmann Mar 1999 A
5891112 Samson Apr 1999 A
5893867 Bagaoisan et al. Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5897536 Nap et al. Apr 1999 A
5902263 Patterson et al. May 1999 A
5906618 Larson, III May 1999 A
5908395 Stalker et al. Jun 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5916193 Stevens et al. Jun 1999 A
5919162 Burns Jul 1999 A
5925016 Chornenky et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928203 Davey et al. Jul 1999 A
5928218 Gelbfish Jul 1999 A
5934284 Plaia et al. Aug 1999 A
5935139 Bates Aug 1999 A
5938645 Gordon Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5941896 Kerr Aug 1999 A
5947995 Samuels Sep 1999 A
5951585 Cathcart et al. Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5976172 Homsma et al. Nov 1999 A
5989210 Morris et al. Nov 1999 A
5989271 Bonnette et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 Mckenzie et al. Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013085 Howard Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6051014 Jang Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059814 Ladd May 2000 A
6068645 Tu May 2000 A
6086605 Barbut et al. Jul 2000 A
6129739 Khosravi Oct 2000 A
6139510 Palermo Oct 2000 A
6142987 Tsugita Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6203561 Ramee et al. Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
6231543 Hegde et al. May 2001 B1
6231545 Kriesel et al. May 2001 B1
6368338 Konya et al. Apr 2002 B1
6398798 Selmon et al. Jun 2002 B2
6428552 Sparks Aug 2002 B1
6500166 Zadno Azizi et al. Dec 2002 B1
6506178 Schubart et al. Jan 2003 B1
6508803 Horikawa et al. Jan 2003 B1
6508825 Selmon et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6514217 Selmon et al. Feb 2003 B1
6533751 Cragg et al. Mar 2003 B2
6533753 Haarstad et al. Mar 2003 B1
6544276 Azizi Apr 2003 B1
6547768 Trotta Apr 2003 B2
6579302 Duerig et al. Jun 2003 B2
6605062 Hurley et al. Aug 2003 B1
6786886 Miller et al. Sep 2004 B2
6837867 Kortelling Jan 2005 B2
7695465 Tomaschko et al. Apr 2010 B2
8292827 Musbach et al. Oct 2012 B2
20080015541 Rosenbluth et al. Jan 2008 A1
20100125244 Mcandrew May 2010 A1
20100168007 Cruise et al. Jul 2010 A1
Foreign Referenced Citations (72)
Number Date Country
2821048 Jul 1980 DE
3417738 Nov 1985 DE
4030998 Apr 1998 DE
0200688 Nov 1986 EP
0293605 Dec 1988 EP
0411118 Feb 1991 EP
0427429 May 1991 EP
0437121 Jul 1991 EP
0472334 Feb 1992 EP
0472368 Feb 1992 EP
0517075 Dec 1992 EP
0533511 Mar 1993 EP
0655228 May 1995 EP
0686379 Dec 1995 EP
0696447 Feb 1996 EP
0737450 Oct 1996 EP
0743046 Nov 1996 EP
0759287 Feb 1997 EP
0771549 May 1997 EP
0784988 Jul 1997 EP
0852132 Jul 1998 EP
0934729 Aug 1999 EP
2580504 Oct 1986 FR
2643250 Aug 1990 FR
2666980 Mar 1992 FR
2768326 Mar 1999 FR
2020557 Jan 1983 GB
2044109 Aug 1983 GB
8187294 Jul 1996 JP
764684 Sep 1980 SU
WO 9203097 Mar 1992 WO
WO 9414389 Jul 1994 WO
WO 9424946 Nov 1994 WO
WO 9601591 Jan 1996 WO
WO 9610375 Apr 1996 WO
WO 9619941 Jul 1996 WO
WO 9623441 Aug 1996 WO
WO 9633677 Oct 1996 WO
WO 9717100 May 1997 WO
WO 9727808 Aug 1997 WO
WO 9742879 Nov 1997 WO
WO 9802084 Jan 1998 WO
WO 9802112 Jan 1998 WO
WO 9823322 Jun 1998 WO
WO 9833443 Aug 1998 WO
WO 9834673 Aug 1998 WO
WO 9836786 Aug 1998 WO
WO 9838920 Sep 1998 WO
WO 9838929 Sep 1998 WO
WO 9839046 Sep 1998 WO
WO 9839053 Sep 1998 WO
WO 9846297 Oct 1998 WO
WO 9847447 Oct 1998 WO
WO 9849952 Nov 1998 WO
WO 9850103 Nov 1998 WO
WO 9851237 Nov 1998 WO
WO 9855175 Dec 1998 WO
WO 9909895 Mar 1999 WO
WO 9922673 May 1999 WO
WO 9923976 May 1999 WO
WO 9925252 May 1999 WO
WO 9930766 Jun 1999 WO
WO 9940964 Aug 1999 WO
WO 9942059 Aug 1999 WO
WO 9944510 Sep 1999 WO
WO 9944542 Sep 1999 WO
WO 9955236 Nov 1999 WO
WO 9958068 Nov 1999 WO
WO 0007655 Feb 2000 WO
WO 0009054 Feb 2000 WO
WO 0016705 Mar 2000 WO
WO 0049970 Aug 2000 WO
Non-Patent Literature Citations (21)
Entry
“Atherosclerotic Disease of the Aortic Arch as a Risk Factor of Recurrent Ischemic Stroke”, The New England Journal of Medicine, 334(18):1216-1221, May 1996.
“Endovascular Grafts, Stents Drive Interventional Radiology Growth”, Cardiovascular Device Update, 2(3):1-12, Mar. 1996.
Cragg et al., “A New Percutaneous Vena Cava Filger,” AJR, 141:601-604, Sep. 1983.
Cragg et al., “Nonsurgical Placement of Arterial Endoprosthesis: A New Technique Using Nitinol Wire”, AJR, 147(1):261-263, Apr. 1983.
Diethrich et al., “Percutaneous Techniques for Endoluminal Carotid Interventions”, J. Endovasc. Surg., 3:182-202, 1996.
Fadali, “A Filtering Device for the Prevention of Particulate Embolization During the Course of Cardiac Surgery”, Surgery, 64(3):634-639, Sep. 1968.
Haissaguerre et al., “Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins”, The New England Journal of Medicine, 339(10):659-666, Sep. 1988.
Jordan, Jr. et al., “Microemboli Detected by Transcranial Doppler Monitoring . . . ”, Cardiovascular Surgery, 7(1)33-38, Jan. 1999.
Karalis et al., “Recognition and Embolic Potential of Intraaortic Atherosclerotic Debris”, American College of Cardiology, 17(1):73-78, Jan. 1991.
Lesh, “Can Catheter Ablation Cure Atrial Fibrillation?”, ACC Current Journal Review, p. 38-40, Sep./Oct. 1997.
Lund et al., “Long-Term Patentcy of Ductus Arteriosus After Balloon Dilation: An Experimental Study”, Laboratory Investigation, 69(4):772-774, Apr. 1984.
Marache et al., “Percutaneous Transluminal Venous Angioplasty . . . ”, American Heart Journal, 125(2 pt. 1):362-366, Feb. 1993.
Mazur et al., “Directional Atherectomy with the Omnicath™: A Unique New Catheter System”, Catheterization and Cardiovascular Diagnosis, 31:17-84, 1994.
Moussa, MD, Issaam, “Stents Don't Require Systemic Anticoagulation . . . But the Technique (and results) Must be Optimal”, Journal of Invasive Cardiol., 8(E):3E-7E, 1996.
Nakanishi et al., “Catheter Intervention to Venous System Using Expandable Metallic Stents”, Rinsho Kyobu Geka, 14(2): English Abstract Only, Apr. 1994.
Onal et al., “Primary Stenting for Complex Atherosclerotic Plaques in Aortic and Iliac Stenoses”, Cardiovascular & Interventional Radiology, 21(5):386-392, 1998.
Theron et al., “New Triple Coaxial Catheter System for Carotid Angioplasty with Cerebral Protection”, American Journal of Neuroradiology, 11:869-874, 1990.
Tunick et al., “Protruding Atheromas in the Thoracic Aortic and Systematic Embolization”, 115(6):423-427, American College of Physicians, 1991.
Tunick et al., “Protruding Atherosclerotic Plaque in the Aortic Archo F Patients with Systemic Embolization: A New Finding Seen by Transesophageal Echocardiography”, American Heart Journal, 120(3):658-660, Sep. 1990.
Waksman et al., “Distal Embolization is Common After Directional Atherectomy . . . ,” American Heart Journal, 129(3):430-435, 1995.
Wholey et al., PTA and Stents in the Treatment of Extracranial Circulation, The Journal of Invasive Cardiology, 8(E):25E-30E, 1996.
Related Publications (1)
Number Date Country
20120253193 A1 Oct 2012 US
Provisional Applications (1)
Number Date Country
61449271 Mar 2011 US